ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 1165408
Boston, MA
Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$94,079,020
-$2,716,980 QoQ
Shares Held
2,823,500
+0.8% QoQ
Ownership
3.21%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,595,586,445 across 121 Biotechnology names. IDYA ranks #12 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,475,611 | $532,503,169 | |
| 2 | RPRX |
Royalty Pharma plc
|
7,480,633 | $358,845,965 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
8,925,010 | $354,501,397 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
12,794,097 | $354,396,486 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
12,809,485 | $267,974,426 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
815,739 | $262,822,948 | |
| 7 | INSM |
INSMED Inc
|
900,000 | $147,168,000 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
737,578 | $124,665,433 |
All Filings in IDYA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,079,020 | 2,823,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $96,796,000 | 2,800,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $78,911,557 | 2,900,094 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,024,735 | 1,238,094 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,460,979 | 1,188,094 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,842,415 | 1,200,094 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,049,377 | 980,094 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $72,505,450 | 2,065,094 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $108,256,655 | 2,467,107 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $104,074,844 | 2,925,094 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $61,702,207 | 2,286,961 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $60,515,085 | 2,575,110 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $36,749,155 | 2,676,559 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,002,327 | 2,201,559 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,603,402 | 1,850,094 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,440,733 | 104,401 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,163,038 | 193,301 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,752,628 | 243,343 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,372,500 | 250,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,561,800 | 407,899 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,935,626 | 507,899 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||